CADL
Candel Therapeutics Inc
9.90$
-3.5%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +27.3% | -19.6% | -0.8% | -1.6% | +0.0% | +0.0% | -1.2% | -19.4% | -16.4% | -8.6% | +14.8% | – | |
| – | +36.9% | +11.1% | +76.5% | -35.7% | +5.1% | -74.8% | +234.4% | +10.8% | +10.9% | +12.6% | +96.8% | – | |
| – | – | -205.3% | – | +91.4% | -12.0% | -345.6% | – | +431.3% | +909.8% | -199.3% | – | – | |
| – | -54.4% | -85.1% | -14.3% | -100.0% | – | +0.0% | +933.3% | +364.5% | +184.0% | +65.0% | -89.8% | – | |
| – | – | – | -14.3% | – | – | +0.0% | +933.3% | +277.4% | +249.6% | +65.0% | -89.8% | – | |
| – | – | +0.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | – | -100.0% | – | – | |
| – | – | +937.2% | – | -13.8% | +5,380.8% | -102.0% | – | -119.3% | – | +113.7% | -74.4% | – | |
| – | – | – | – | – | – | -112.2% | – | -261.0% | – | +128.2% | -91.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.